Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000715812-19-000026
Filing Date
2019-12-16
Accepted
2019-12-16 15:31:55
Documents
43
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 bsyn20191031.htm 10-Q 182872
8 CERTIFICATON OF CHIEF EXECUTIVE OFFICER bysnx311.htm EX-31.1 11735
9 CERTIFICATION OF CHIEF ACCOUNTING OFFICER bsynx312.htm EX-31.2 10762
10 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION bsynx321.htm EX-32.1 4847
11 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION bsynx322.htm EX-32.2 4421
  Complete submission text file 0000715812-19-000026.txt   1250677

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE bsyn-20191031.xml EX-101.INS 153174
3 XBRL SCHEMA FILE bsyn-20191031.xsd EX-101.SCH 16290
4 XBRL CALCULATION FILE bsyn-20191031_cal.xml EX-101.CAL 37319
5 XBRL DEFINITION FILE bsyn-20191031_def.xml EX-101.DEF 20135
6 XBRL LABEL FILE bsyn-20191031_lab.xml EX-101.LAB 119643
7 XBRL PRESENTATION FILE bsyn-20191031_pre.xml EX-101.PRE 90933
Mailing Address 55 WEST MONROE STREET STE 1200 CHICAGO IL 60603
Business Address 55 WEST MONROE STREET STE 1200 CHICAGO IL 60603 8479560471
BIOSYNERGY INC (Filer) CIK: 0000715812 (see all company filings)

EIN.: 362880990 | State of Incorp.: IL | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-12459 | Film No.: 191286897
SIC: 3829 Measuring & Controlling Devices, NEC